Limited-Time Offer for New Patients: Start GLP-1 Medical Weight Loss & Treat Stubborn Belly Fat with 4 Complimentary BTL Vanquish ME Treatments ($2,600 Value).
Skip to main content

Autoimmune Mechanisms in the Gut are Silent Drivers of Parkinsons's Disease

Dysbiosis

New findings in mice suggest autoimmune mechanisms that originate in the gut are silent drivers of Parkinson’s disease

Parkinson’s disease is caused by the progressive loss of dopaminergic neurons and recent studies have widened the immune system and the gut microbiota‘s contribution to the disease.

A new study in mice, led by researchers from the Université de Montréal and McGill University in Canada, shows the involvement of intestinal infections as a trigger in Parkinson’s disease through autoimmune mechanisms.

Previous in vitro and in vivo data showed that mutations in the genes PINK1 and PRKN are involved in the autophagy of damaged mitochondria (commonly referred to as mitophagy) and also play an active role in repressing mitochondrial antigen presentation. These findings suggest that autoimmune mechanisms could likely be involved in Parkinson’s disease.

However, the fact that contradictory findings have also been observed in mice led Matheoud and colleagues to explore other triggers.

In the current study, the infection of mice that did not express PINK1 and/or PRKN with the Gram-negative bacterium Citrobacter rodentium triggered mitochondrial antigen presentation in the periphery. Furthermore, the intestinal infection led to cytotoxic CD8+ T cells being established, which targeted dopaminergic neurons in the brain, whereas non-dopaminergic neurons were not affected.

The induction of microbial antigen presentation was also found after infecting mouse macrophage-like cell lines with Gram-negative bacteria (even when heat-killed) but not with Gram-positive bacteria, whereas it was abolished in the presence of Parkin (encoded by PRKN).

Furthermore, infected mice also showed a more than 40% drop in the number of dopaminergic axons in the striatum, along with motor impairment—both classic Parkinson’s disease-like markers—which was reversed after treatment with L-DOPA.

On the whole, these preliminary findings in mice show that PINK1 kinase genes are major repressors of adaptive immune responses and their absence may contribute to the development of Parkinson’s disease under a stressor, such as an intestinal infection.

The contribution of autoimmune mechanisms to Parkinson’s disease opens up new avenues for developing preventive therapeutic approaches. Other origins of Parkinson’s disease involving the gut-brain axis are also currently the subject of active research.

Reference:

Matheoud D, Cannon T, Voisin A, et al. Intestinal infection triggers Parkinson’s disease-like symptoms in Pink1-/- miceNature. 2019. doi: 10.1038/s41586-019-1405-y.

Author
David Bauder David J. Bauder, PA-C David Bauder, PA-C, is a certified physician assistant and the assistant medical director at Weight Loss and Vitality in Manassas and Alexandria, Virginia, Washington, DC; and Gaithersburg, MD. He enjoys helping patients optimize their physical and mental health to improve their overall well-being. He earned his physician assistant degree from the University of Texas Health Science Center at San Antonio. Afterward, he gained admission into the reputable graduate program for physician assistant studies at the University of Nebraska Health Science Center in Omaha. David has over 26 years of experience working as a physician assistant. He’s practiced in podiatry, family medicine, emergency medicine, general surgery, urgent care, and functional medicine.

You Might Also Enjoy...

A blue, futuristic medical graphic showing a side profile of a human head with a brightly glowing brain and neural pathways,

How SEMAX supports Brain Function and Cognitive Performance

Semax is a neuroactive peptide with early evidence suggesting potential cognitive and neuroprotective benefits, but its clinical use remains limited by insufficient large-scale human data, regulatory restrictions, and an uncertain safety profile.
A blue, science-themed graphic showing a side profile of a human head with a glowing brain and a clock embedded inside it, sy

How DSIP Supports Sleep and Recovery

DSIP is a naturally occurring peptide that shows potential for improving sleep quality and treating insomnia through neurotransmitter regulation, but its clinical use is limited by small study sizes, lack of FDA approval, and an uncertain safety profile.
A blue, science-themed graphic showing a cross-section of skin with hair follicles growing upward, surrounded by glowing mole

How GHK-Cu Benefits Skin & Hair

GHK-Cu is a copper-binding peptide with promising roles in skin regeneration and tissue repair, but its broader medical use is limited by insufficient human data, regulatory restrictions, and an incompletely defined safety profile.
A blue, science-themed graphic showing a glowing human silhouette and a large DNA double helix, with the headline “How Epital

How Epitalon Supports Longevity and Health

Epitalon is a research peptide with early evidence suggesting potential anti-aging and neuroprotective benefits, but its clinical use is limited by scarce human data, regulatory concerns, and an uncertain safety profile.
BPC-157 image of a knee

How BPC-157 Benefits Healing and Recovery

BPC-157 is a naturally occurring gastric peptide that shows promising preclinical potential for tissue healing and anti-inflammatory effects, but lacks sufficient human evidence and carries significant safety and regulatory concerns due to its unapproved a